Atalanta Therapeutics
Boston, United States · $207.0M raised
- Headquarters
- Boston
- Business Model
- B2B
- Website
- atalantatx.com
- Total Funding
- $207.0M
- Last Round
- $97.0M Series BJan 2025
- Rounds
- 2
About
Clinical-stage biotech developing branched siRNA therapeutics for neurological diseases using Nobel-winning RNAi discoveries.
Summary
Atalanta Therapeutics is a Biotech company based in Boston, United States. It has raised $207.0M in total across 2 rounds, most recently a $97.0M Series B round in Jan 2025. Investors include EQT AB and F-Prime Capital.
Tech & App Stack
8 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.